Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2006
08/22/2006US7094957 Hybrid maize 33D11
08/22/2006US7094955 Inbred corn line N61060
08/22/2006US7094953 Plant retroelements and methods related thereto
08/22/2006US7094951 Comprises expression vector coding nucleotide sequences which confer resistance to fungal infection (Pi2) for use in transformation and generation of disease resistant rice; biological pest control; disease resistant and plants
08/22/2006US7094948 Transgenic animals
08/22/2006US7094945 polynucleotides, small interfering RNA or genetic vectors that inhibit expression of genes that code for osmosis stress resistance proteins, used as nematocides
08/22/2006US7094943 Solution phase biopolymer synthesis
08/22/2006US7094892 Nucleotide sequences coding polypeptide for use as tools in genetic engineering
08/22/2006US7094891 Introducing a gene operably linked to an isolated nucleotide sequence into a cell in vitro, expressing the sequence to produce a transcriptional activator protein, thereby increasing the transcription of the gene
08/22/2006US7094888 Cypridina luciferase fusion for use as diagnostic tool in monitoring synaptic response
08/22/2006US7094886 Evi27 gene sequences and protein encoded thereby
08/22/2006US7094884 A protein containing an amyloid beta (A beta ) peptide, a peptidyl prolyl isomerase chaperone,wherein the PrP and the peptidyl prolyl isomerase chaaperone are covalently linked, and such protein is soluble to at least 100 nM in a solution with a pH of 7.4 contains 20 nM sodium phosphate and 150 nM NaCl
08/22/2006US7094883 Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
08/22/2006US7094882 Growth factor which acts through erb b-4 rtk
08/22/2006US7094880 Decorin proteoglycan inhibitor of fibrinogen blood clotting
08/22/2006US7094879 Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof
08/22/2006US7094878 Aortic carboxypeptidase-like polypeptide
08/22/2006US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders
08/22/2006US7094876 Human cDNAs and proteins and uses thereof
08/22/2006US7094875 With advantages such as ability of the polypeptides to preferentially bind a CD28/CTLA-4 receptor at a level greater or less than the ability of human B7-1, inhibit altered level of T cell proliferation response greater than human B7-1
08/22/2006US7094874 Soluble CTLA4 mutant molecules
08/22/2006US7094873 Polypeptide that interacts with heat shock proteins
08/22/2006US7094869 Animal growth regulators
08/22/2006US7094767 Polynucleotide herpes virus vaccine
08/22/2006US7094761 A GPCR-like protein for treating glaucoma
08/22/2006US7094759 peptide having a specific amino acid sequence suppresses initial adhesion of intraoral bacteria to teeth and periodontal tissue and prevents formation of a biofilm in an oral cavity.
08/22/2006US7094758 Apoptotic compounds
08/22/2006US7094757 diagnosis of transmissible spongiform encephalopathies (TSEs) especially in an immunoassay, as well as its use as an immunogen; genetic engineering
08/22/2006US7094756 relates to the surprising finding that overexpression of ABIN prevents TNF-induced lethal hepatitis in mice
08/22/2006US7094755 Therapy and prophylaxis of cancer
08/22/2006US7094754 Inhibitors of matrix metalloproteinases; chemoattractants for cell proliferation of fibroblasts and/or keratinocytes
08/22/2006US7094753 Somatostatin analog and uses thereof
08/22/2006US7094750 Toxin for use in treating cancer; antitumor agents
08/22/2006US7094606 Improving existing lines of plants and development of new lines having desired traits by making a specific alteration of a specific pre-existing gene of a plant
08/22/2006US7094600 Screen for sodium channel modulators
08/22/2006US7094599 Therapeutic cells which express a membrane-bound, chimeric, proteinaceous receptor comprising an extracellular CD4 fragment to bind an HIV-infected cell without contracting the infection and an intracellular portion to destroy it
08/22/2006US7094598 gene expression vectors comprising enhancers having sequence identity to dna sequences, that elicit immune responses against viral disease
08/22/2006US7094597 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
08/22/2006US7094584 strains of corynebacterium having lysine export carrier, dihydrodipicolinate synthase, aspartokinase and dihydrodipicolinate reductase gene overexpression; genetic vectors and host cells comprising nucleotide sequences linked to these genes; biosynthesis
08/22/2006US7094580 Methods for producing pure perlecan and other heparan sulfate proteoglycans
08/22/2006US7094577 Insulin and albumin fusion protein
08/22/2006US7094576 Detecting helminth infection using synthetic larval proteins; immunoassay; parasiticides
08/22/2006US7094575 For prophylaxis and therapy of phospholipase A2 (PLA2) related inflammatory conditions
08/22/2006US7094572 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
08/22/2006US7094570 Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
08/22/2006US7094569 Polypeptide for use in the treatment and prevention of alopecia
08/22/2006US7094566 IL-17 receptor like molecules and uses thereof
08/22/2006US7094564 polynucleotides that code for lymphotoxin polypeptide receptors, used for screening antagonists and/or agonists to the receptors; genetic engineering
08/22/2006US7094556 Diagnosis and treatment of malignant neoplasms
08/22/2006US7094554 Cry proteins; for crop growth and development; pesticides
08/22/2006US7094552 Diagnostic test kits
08/22/2006US7094550 Diagnosing atherosclerosis in humans; obtain blood, incubate with confining complex, detect signal from bound complex, evaluate for atherosclerosis
08/22/2006US7094549 mass spectroscopy; medical diagnosis/prognosis; kits
08/22/2006US7094548 Polypeptide for use in purifying and separation of target peptides
08/22/2006US7094547 Sperm specific proteins
08/22/2006US7094529 Detecting preferential enzyme inhibitors; obtain cell extracts contain caspase, incubate with activator and test inhibitor, measure caspase activation, reduced caspase activation, indicates enzyme inhibitor
08/22/2006US7094411 Avirulent, immunogenic flavivirus chimeras
08/22/2006US7094409 Antigen arrays for treatment of allergic eosinophilic diseases
08/22/2006US7094407 Self cell-penetrating Tat peptide having a self penetrating signal is bound to a human Type-I collagen C-terminal derived peptide
08/22/2006US7094406 Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof
08/22/2006US7094405 Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients
08/22/2006US7094391 oral Lime disease vaccination using pure Outer surface protein A specific serum Immunoglobulin A antibodies; immunotherapy
08/22/2006US7094201 System and method for genetically treating cardiac conduction disturbances
08/22/2006CA2158960C Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter
08/22/2006CA2097878C Therapeutic agent for neutropenia
08/22/2006CA2044468C Canine granulocyte macrophage colony stimulating factor
08/17/2006WO2006086769A2 Gip analog and hybrid polypeptides with selectable properties
08/17/2006WO2006086760A2 Diagnostic measurement of disease
08/17/2006WO2006086454A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
08/17/2006WO2006086204A1 Porcine intrinsic factor
08/17/2006WO2006085749A1 Plant virus designated tomato torrado virus
08/17/2006WO2006085648A1 Novel narcolepsy-related gene
08/17/2006WO2006085612A1 Method for preparation of neural stem cells
08/17/2006WO2006085583A1 Cell permeable peptide
08/17/2006WO2006085482A1 Self-replication factor and amplification method of hematopoietic stem cell
08/17/2006WO2006085411A1 Novel adjuvant for evoking immune responce and utilization of the same
08/17/2006WO2006085121A2 Vgp peptide fragments as biomarkers for schizophrenic and bipolar disorders
08/17/2006WO2006085092A2 Methods and uses of antibodies in the purification of interferon
08/17/2006WO2006085088A1 New detoxification method
08/17/2006WO2006084888A2 C-terminally pegylated growth hormones
08/17/2006WO2006084746A1 Replication-deficient rna viruses as vaccines
08/17/2006WO2006084735A1 Gene for coenzyme pqq synthesis protein b from gluconobacter oxydans
08/17/2006WO2006084725A1 Novel gene sts 16
08/17/2006WO2006084712A2 Novel gene rcs 27
08/17/2006WO2006084711A2 Novel gene sts 22
08/17/2006WO2006084710A2 Novel gene vcs 02
08/17/2006WO2006084705A2 Novel gene sts 06
08/17/2006WO2006084704A2 Novel gene sts 01
08/17/2006WO2006084703A2 Novel gene sts 24
08/17/2006WO2006084664A1 Novel gene rcs 09
08/17/2006WO2006084646A2 Sms 22 gene and gene product that plays a role in the synthesis of vitamin c
08/17/2006WO2006084645A1 Novel gene rcs 10
08/17/2006WO2006084643A2 Novel gene vcs 07
08/17/2006WO2006084642A2 Microorganisms with a disruption of the respiratory chain gene rcs26 for the production of vitamin c
08/17/2006WO2006084466A2 Surface-located streptococcus pneumoniae polypeptides
08/17/2006WO2006084388A1 Monomeric streptavidin muteins
08/17/2006WO2006084383A1 Anti-diabetic or anti-hypertensive dietary supplement
08/17/2006WO2006084337A1 A molecule and chimeric molecules thereof
08/17/2006WO2006084327A1 A molecule and chimeric molecules thereof
08/17/2006WO2006068720A3 Hematopoietic cell selectin ligand polypeptides and methods of use thereof